Not Tagged
Not Tagged
['pancreatic']
neoadjuvant folfirinox does not provide a survival benefit over upfront surgery in resectable pancreatic cancer, a phase 2 study suggests. #asco23 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.